Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N M Dean

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Biochemistry|July 22, 1999
Ser/Thr protein phosphatase type 5 (PP5) is a negative regulator of glucocorticoid receptor-mediated growth arrestZ Zuo, G Urban, J G Scammell, et al.
British Journal of Pharmacology|September 14, 1999
Antisense down-regulation of thymidylate synthase to suppress growth and enhance cytotoxicity of 5-FUdR, 5-FU and Tomudex in HeLa cellsP J Ferguson, O Collins, N M Dean, et al.
The Journal of Biological Chemistry|March 6, 1999
Up-regulation of the Pit-2 phosphate transporter/retrovirus receptor by protein kinase C epsilonZ Jobbagy, Z Olah, G Petrovics, et al.
Molecular Pharmacology|October 1, 1996
Inhibition of expression of the multidrug resistance-associated P-glycoprotein of by phosphorothioate and 5' cholesterol-conjugated phosphorothioate antisense oligonucleotidesS K Alahari, N M Dean, M H Fisher, et al.
Cancer Research|March 31, 2001
p27Kip1 is required for PTEN-induced G1 growth arrestA R Gottschalk, D Basila, M Wong, et al.
Nucleic Acids Research|February 1, 1996
Enhanced activity of an antisense oligonucleotide targeting murine protein kinase C-alpha by the incorporation of 2'-O-propyl modificationsR A McKay, L L Cummins, M J Graham, et al.
Anti-Cancer Drug Design|July 1, 1997
Antisense oligonucleotide inhibitors of isozymes of protein kinase C: in vitro and in vivo activity, and clinical development as anti-cancer therapeuticsK McGraw, R McKay, L Miraglia, et al.
The Journal of Biological Chemistry|April 3, 2001
Insulin regulates alternative splicing of protein kinase C beta II through a phosphatidylinositol 3-kinase-dependent pathway involving the nuclear serine/arginine-rich splicing factor, SRp40, in skeletal muscle cellsN A Patel, C E Chalfant, J E Watson, et al.
Molecular Pharmacology|August 1, 1996
Treatment of glioblastoma U-87 by systemic administration of an antisense protein kinase C-alpha phosphorothioate oligodeoxynucleotideT Yazaki, S Ahmad, A Chahlavi, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 13, 2001
Pharmacokinetics and pharmacodynamics of an antisense phosphorothioate oligonucleotide targeting Fas mRNA in miceR Z Yu, H Zhang, R S Geary, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Biochemistry|July 22, 1999
Ser/Thr protein phosphatase type 5 (PP5) is a negative regulator of glucocorticoid receptor-mediated growth arrestZ Zuo, G Urban, J G Scammell, et al.
British Journal of Pharmacology|September 14, 1999
Antisense down-regulation of thymidylate synthase to suppress growth and enhance cytotoxicity of 5-FUdR, 5-FU and Tomudex in HeLa cellsP J Ferguson, O Collins, N M Dean, et al.
The Journal of Biological Chemistry|March 6, 1999
Up-regulation of the Pit-2 phosphate transporter/retrovirus receptor by protein kinase C epsilonZ Jobbagy, Z Olah, G Petrovics, et al.
Molecular Pharmacology|October 1, 1996
Inhibition of expression of the multidrug resistance-associated P-glycoprotein of by phosphorothioate and 5' cholesterol-conjugated phosphorothioate antisense oligonucleotidesS K Alahari, N M Dean, M H Fisher, et al.
Cancer Research|March 31, 2001
p27Kip1 is required for PTEN-induced G1 growth arrestA R Gottschalk, D Basila, M Wong, et al.
Nucleic Acids Research|February 1, 1996
Enhanced activity of an antisense oligonucleotide targeting murine protein kinase C-alpha by the incorporation of 2'-O-propyl modificationsR A McKay, L L Cummins, M J Graham, et al.
Anti-Cancer Drug Design|July 1, 1997
Antisense oligonucleotide inhibitors of isozymes of protein kinase C: in vitro and in vivo activity, and clinical development as anti-cancer therapeuticsK McGraw, R McKay, L Miraglia, et al.
The Journal of Biological Chemistry|April 3, 2001
Insulin regulates alternative splicing of protein kinase C beta II through a phosphatidylinositol 3-kinase-dependent pathway involving the nuclear serine/arginine-rich splicing factor, SRp40, in skeletal muscle cellsN A Patel, C E Chalfant, J E Watson, et al.
Molecular Pharmacology|August 1, 1996
Treatment of glioblastoma U-87 by systemic administration of an antisense protein kinase C-alpha phosphorothioate oligodeoxynucleotideT Yazaki, S Ahmad, A Chahlavi, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 13, 2001
Pharmacokinetics and pharmacodynamics of an antisense phosphorothioate oligonucleotide targeting Fas mRNA in miceR Z Yu, H Zhang, R S Geary, et al.
Pageof 8